Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
99.93
+3.13 (3.23%)
May 29, 2026, 3:00 PM CST
0.48% (1Y)
| Market Cap | 26.45B -3.1% |
| Revenue (ttm) | 1.55B +161.4% |
| Net Income | 497.93M |
| EPS | 1.88 |
| Shares Out | 264.71M |
| PE Ratio | 53.13 |
| Forward PE | 47.74 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,542,741 |
| Open | 96.70 |
| Previous Close | 96.80 |
| Day's Range | 93.10 - 100.97 |
| 52-Week Range | 75.10 - 134.17 |
| Beta | 0.02 |
| Analysts | Strong Buy |
| Price Target | 147.03 (+47.13%) |
| Earnings Date | Aug 28, 2026 |